Conditions: Cancer: Solid Tumors
Keywords: Cancer, solid tumors
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 27
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the maximum tolerable dose (MTD) and the related effects of E7080 administered to patients with solid tumors that are resistant to approved existing anti-tumor therapies, or for which no appropriate treatment is available.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: E7080
Intervention descriptions: intervention 1: E7080 is administered orally twice a day for 2 weeks to patients with solid tumors that are resistant to approved conventional therapies or for which no appropriate treatment is available.

Protocol document: